3rd International Conference on Chemo and BioInformatics, Kragujevac, September 25-26. 2025. (pp. 599-602)
AUTOR(I) / AUTHOR(S): Kristina D. Milisavljević, Jelena R. Đorović Jovanović, Marko R. Antonijević, Žiko B. Milanović
Download Full Pdf 
DOI: 10.46793/ICCBIKG25.599M
SAŽETAK / ABSTRACT:
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline, oxidative stress, and cholinergic dysfunction. Current therapies offer limited efficacy, highlighting the need for new neuroprotective agents. Tetrahydrocannabinol (THC), the main psychoactive component of cannabis, exhibits antioxidant and neuroprotective properties, but its clinical use is restricted due to psychoactivity. To overcome this, a series of structurally modified THC derivatives were designed using a computer-aided drug design approach aimed at enhancing drug-likeness and reducing adverse effects. Derivatives were evaluated for pharmacokinetic properties, synthetic accessibility, and antioxidant potential. Molecular docking simulations were used to assess binding interactions with acetylcholinesterase (AChE), a key enzyme involved in AD pathology. Among all derivatives, THC3 and THC53 emerged as the most promising, demonstrating strong binding to AChE and favorable physicochemical profiles. These findings support their potential as multifunctional agents for AD treatment, combining acetylcholinesterase inhibition with antioxidant neuroprotection. Together, these results highlight the potential of rational drug design in developing new therapies for neurodegenerative diseases.
KLJUČNE REČI / KEYWORDS:
Alzheimer’s disease, tetrahydrocannabinol (THC), acetylcholinesterase (AChE), molecular docking
PROJEKAT / ACKNOWLEDGEMENT:
This research is funded by the Ministry of Science, Technological Development and Innovation, Republic of Serbia, Grants: No. 451-03-136/2025-03/200378.
LITERATURA / REFERENCES:
- Ł.J. Walczak-Nowicka, M. Herbet, Acetylcholinesterase inhibitors in the treatment of neurodegenerative diseases and the role of acetylcholinesterase in their pathogenesis, Int. J. Mol. Sci., 22 (2021) 9290.
- S. Bhatt, L. Puli, C.R. Patil, Role of reactive oxygen species in the progression of Alzheimer’s disease, Drug Discov. Today, 26 (2021) 794–803.
- R. B. Malabadi, K.P. Kolkar, R.K. Chalannavar, Δ9-Tetrahydrocannabinol (THC): The major psychoactive component is of botanical origin, Int. J. Innov. Sci. Res. Rev., 5 (2023) 4177–4184.
- E. G. Guzman-Lopez, M. Reina, A. Perez-Gonzalez, M. Francisco-Marquez, L.F. Hernandez- Ayala, R. Castañeda-Arriaga, A. Galano, CADMA-Chem: a computational protocol based on chemical properties aimed to design multifunctional antioxidants, International Journal of Molecular Sciences, 23 (2022) 13246.
- L. Fu, S. Shi, J. Yi, N. Wang, Y. He, Z. Wu, D. Cao, ADMETlab 3.0: an updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support, Nucleic Acids Research, (2024) gkae236.
- G. M. Morris, R. Huey, W. Lindstrom, M.F. Sanner, R.K. Belew, D.S. Goodsell, A.J. Olson, AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility, Journal of Computational Chemistry, 30 (2009) 2785–2791.
- G. M. Morris, D.S. Goodsell, R.S. Halliday, R. Huey, W.E. Hart, R.K. Belew, A.J. Olson, Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function, Journal of Computational Chemistry, 19 (1998) 1639–1662.
- J. Cheung, M.J. Rudolph, F. Burshteyn, M.S. Cassidy, E.N. Gary, J. Love, J.J. Height, Structures of human acetylcholinesterase in complex with pharmacologically important ligands, J. Med. Chem., 55 (2012) 10282–10286
- K. Milisavljević, Ž. Milanović, Multifunctional tetrahydrocannabinol derivatives as potential antioxidant neuroprotectors: Computer-aided design and analysis, J. Comput. Biophys. Chem., submitted for publication (2025).